C19orf12

chromosome 19 open reading frame 12

Basic information

Region (hg38): 19:29698937-29715789

Previous symbols: [ "SPG43" ]

Links

ENSG00000131943NCBI:83636OMIM:614297HGNC:25443Uniprot:Q9NSK7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • neurodegeneration with brain iron accumulation 4 (Strong), mode of inheritance: AD
  • neurodegeneration with brain iron accumulation 4 (Strong), mode of inheritance: AR
  • hereditary spastic paraplegia 43 (Limited), mode of inheritance: AR
  • neurodegeneration with brain iron accumulation 4 (Strong), mode of inheritance: AR
  • neurodegeneration with brain iron accumulation 4 (Definitive), mode of inheritance: Semidominant
  • neurodegeneration with brain iron accumulation 4 (Strong), mode of inheritance: AR
  • neurodegeneration with brain iron accumulation 4 (Strong), mode of inheritance: AR
  • hereditary spastic paraplegia 43 (Limited), mode of inheritance: AR
  • hereditary spastic paraplegia 43 (Limited), mode of inheritance: AR
  • neurodegeneration with brain iron accumulation 4 (Moderate), mode of inheritance: AD
  • neurodegeneration with brain iron accumulation 4 (Definitive), mode of inheritance: AR
  • neurodegeneration with brain iron accumulation 4 (Moderate), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Neurodegeneration with brain iron accumulation 4; Spastic paraplegia 43AD/ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic21981780; 22508347; 23269600; 23447832; 23494994; 23521069; 23857908; 26187298; 29295770; 30298423; 31087512

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the C19orf12 gene.

  • Neurodegeneration with brain iron accumulation 4 (2 variants)
  • Spastic ataxia (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the C19orf12 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
29
clinvar
1
clinvar
32
missense
6
clinvar
55
clinvar
1
clinvar
1
clinvar
63
nonsense
1
clinvar
1
clinvar
2
start loss
2
clinvar
2
frameshift
3
clinvar
7
clinvar
6
clinvar
16
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
2
2
non coding
1
clinvar
84
clinvar
33
clinvar
41
clinvar
159
Total 3 16 150 63 43

Highest pathogenic variant AF is 0.00000657

Variants in C19orf12

This is a list of pathogenic ClinVar variants found in the C19orf12 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-29698967-C-T Neurodegeneration with brain iron accumulation 4 Uncertain significance (Jan 13, 2018)328653
19-29699015-G-A Neurodegeneration with brain iron accumulation 4 Uncertain significance (Jan 13, 2018)888719
19-29699040-G-A Neurodegeneration with brain iron accumulation 4 Uncertain significance (Jan 12, 2018)328654
19-29699141-G-A Neurodegeneration with brain iron accumulation 4 Benign (Jan 13, 2018)328655
19-29699192-G-A Neurodegeneration with brain iron accumulation 4 Uncertain significance (Jan 12, 2018)328656
19-29699194-G-A Neurodegeneration with brain iron accumulation 4 Uncertain significance (Jan 12, 2018)888720
19-29699194-G-T Neurodegeneration with brain iron accumulation 4 Benign (Jan 13, 2018)328657
19-29699220-C-A Neurodegeneration with brain iron accumulation 4 Uncertain significance (Jan 12, 2018)328658
19-29699249-C-T Neurodegeneration with brain iron accumulation 4 Benign (Jan 12, 2018)328659
19-29699295-G-A Neurodegeneration with brain iron accumulation 4 Uncertain significance (Jan 12, 2018)328660
19-29699309-T-TA Neurodegeneration with brain iron accumulation 4 Uncertain significance (Jun 14, 2016)328661
19-29699312-A-T Neurodegeneration with brain iron accumulation 4 Uncertain significance (Jan 12, 2018)890421
19-29699312-A-AT Neurodegeneration with brain iron accumulation 4 Likely benign (Jun 14, 2016)328662
19-29699340-G-A Neurodegeneration with brain iron accumulation 4 Benign (Jan 13, 2018)328663
19-29699355-C-T Neurodegeneration with brain iron accumulation 4 Uncertain significance (Apr 27, 2017)890422
19-29699360-G-A Neurodegeneration with brain iron accumulation 4 Uncertain significance (Jan 12, 2018)890423
19-29699375-C-T Neurodegeneration with brain iron accumulation 4 Uncertain significance (Jan 12, 2018)328664
19-29699376-G-A Neurodegeneration with brain iron accumulation 4 Benign (Jan 13, 2018)328665
19-29699398-G-A Neurodegeneration with brain iron accumulation 4 Uncertain significance (Jan 13, 2018)890993
19-29699408-A-G Neurodegeneration with brain iron accumulation 4 Likely benign (Jan 12, 2018)328666
19-29699412-G-A Neurodegeneration with brain iron accumulation 4 Uncertain significance (Jan 12, 2018)890994
19-29699418-G-C Neurodegeneration with brain iron accumulation 4 Uncertain significance (Jan 13, 2018)328667
19-29699424-A-C Neurodegeneration with brain iron accumulation 4 Uncertain significance (Jan 12, 2018)328668
19-29699440-G-A Neurodegeneration with brain iron accumulation 4 Uncertain significance (Jan 13, 2018)890995
19-29699470-G-A Neurodegeneration with brain iron accumulation 4 Uncertain significance (Jan 12, 2018)328669

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
C19orf12protein_codingprotein_codingENST00000392278 314644
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.3440.6041257140321257460.000127
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.3908494.70.8870.00000631976
Missense in Polyphen1720.8860.81395265
Synonymous-0.7855245.31.150.00000379322
Loss of Function1.5214.460.2241.92e-755

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002230.000213
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00009240.0000924
European (Non-Finnish)0.0001880.000185
Middle Eastern0.000.00
South Asian0.0001310.000131
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Disease
DISEASE: Neurodegeneration with brain iron accumulation 4 (NBIA4) [MIM:614298]: A neurodegenerative disorder associated with iron accumulation in the brain, primarily in the basal ganglia. NBIA4 results in speech difficulty, extrapyramidal signs, oromandibular and generalized dystonia, and parkinsonism. Most patients have progressive involvement of the corticospinal tract, with spasticity, hyperreflexia, and extensor plantar responses. {ECO:0000269|PubMed:21981780, ECO:0000269|PubMed:22508347, ECO:0000269|PubMed:22584950, ECO:0000269|PubMed:22704260, ECO:0000269|PubMed:23269600, ECO:0000269|PubMed:23278385, ECO:0000269|PubMed:23521069, ECO:0000269|PubMed:23857908, ECO:0000269|PubMed:25592411, ECO:0000269|PubMed:26136767, ECO:0000269|PubMed:26187298}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spastic paraplegia 43, autosomal recessive (SPG43) [MIM:615043]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SP43 is characterized by childhood onset of progressive spasticity affecting the lower and upper limbs. {ECO:0000269|PubMed:23857908}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Intolerance Scores

loftool
0.0410
rvis_EVS
0.26
rvis_percentile_EVS
70.06

Haploinsufficiency Scores

pHI
0.119
hipred
N
hipred_score
0.199
ghis
0.392

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
gene_indispensability_score

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
1600014C10Rik
Phenotype

Gene ontology

Biological process
autophagy;apoptotic process;response to oxidative stress;mitochondrial calcium ion homeostasis
Cellular component
mitochondrion;endoplasmic reticulum;cytosol;integral component of membrane;mitochondrial membrane
Molecular function